India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’
Published . Updated .
Case filed in 2022 by patient unable to afford medicine leads to cap on drug prices for millions who face ruin if diagnosed The Indian government has moved to reduce the price of cancer drugs after a retired bank clerk took her case to the supreme court. From next month, 137 cancer drugs in India will be cheaper as the government tries to tackle the tragedy of poorer patients either forgoing treatment, selling land or falling into debt to meet the high cost of some medicines, which are making large profits for hospitals and pharmacists. Continue reading...
Directly affected
- No company is named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drugs” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drugs” (pharma and health) in this story.
- XLF Financial Select Sector SPDR-3.9% 30d
Financial Select Sector SPDR: it holds banks. Linked by “bank” (banks) in this story.
- INDA iShares MSCI India ETF-5.0% 30d
iShares MSCI India ETF holds stocks listed in India, which this story is about (“india”).
- EMB iShares J.P. Morgan USD Emerging Markets Bond ETF-2.1% 11d
iShares J.P. Morgan USD Emerging Markets Bond ETF holds emerging-market government bonds, which react to inflation and interest-rate news like this one in India
- EMLC VanEck J.P. Morgan EM Local Currency Bond ETF-1.1% 30d
VanEck J.P. Morgan EM Local Currency Bond ETF holds emerging-market bonds in local currencies, which move with rate and currency news like this from India.
- EEM iShares MSCI Emerging Markets ETF-0.3% 30d
iShares MSCI Emerging Markets ETF is a broad fund of emerging-market stocks that includes India
- LLY Eli Lilly and+11.9% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drugs” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| XBINo price data for this ticker | — | — | — | — | — | — | — |
| XLFNo price data for this ticker | — | — | — | — | — | — | — |
| INDANo price data for this ticker | — | — | — | — | — | — | — |
| EMBNo price data for this ticker | — | — | — | — | — | — | — |
| EMLCNo price data for this ticker | — | — | — | — | — | — | — |
| EEMNo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Case filed in 2022 by patient unable to afford medicine leads to cap on drug prices for millions who face ruin if diagnosed The Indian government has moved to reduce the price of cancer drugs after a retired bank clerk took her case to the…
Source: The Guardian
Members of Congress who traded Select Sector Spdr Tr (XLV) near this story
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLV)
Companies tied to this story
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 23 Oct 2026 story “India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’.” Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drugs” (pharma and health) in this story
- XBI Spdr Series Trust
Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence in the 23 Oct 2026 story “India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’.” Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drugs” (pharma and health) in this story
- XLF Select Sector Spdr Tr
In “India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’,” Select Sector Spdr Tr (XLF) is linked, with no stored direction, medium confidence. Reason on file: Financial Select Sector SPDR: it holds banks. Linked by “bank” (banks) in this story
- INDA Ishares Tr
For “India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’,” Ishares Tr (INDA) is linked, with no stored direction, medium confidence. Reason on file: iShares MSCI India ETF holds stocks listed in India, which this story is about (“india”)
- EMB Ishares Tr
Ishares Tr (EMB) is linked, with no stored direction, medium confidence in the 23 Oct 2026 story “India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’.” Reason on file: iShares J.P. Morgan USD Emerging Markets Bond ETF holds emerging-market government bonds, which react to inflation and interest-rate news like this one in India
- EMLC Vaneck J. P. Morgan Em Local Currency Bond Etf
In “India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’,” Vaneck J. P. Morgan Em Local Currency Bond Etf (EMLC) is linked, with no stored direction, medium confidence. Reason on file: VanEck J.P. Morgan EM Local Currency Bond ETF holds emerging-market bonds in local currencies, which move with rate and currency news like this from India
- EEM Ishares Tr
Ishares Tr (EEM) is linked, with no stored direction, medium confidence in the 23 Oct 2026 story “India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’.” Reason on file: iShares MSCI Emerging Markets ETF is a broad fund of emerging-market stocks that includes India
- LLY Eli Lilly
Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 23 Oct 2026 story “India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’.” Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drugs” (pharma and health) in this story
Select Sector Spdr Tr (XLV)
On 23 Oct 2026, “India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’” is the story that connects Select Sector Spdr Tr (XLV) to this story.
Select Sector Spdr Tr (XLV) is on the page because Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drugs” (pharma and health) in this story
Spdr Series Trust (XBI) is here too. Its reason reads: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drugs” (pharma and health) in this story
Dates in the story, and the Select Sector Spdr Tr (XLV) price range
XBI traded between 152.63 and 158.97 across 2 sessions. The latest close on file is 154.01. XLF traded between 52.82 and 56.03 across 20 sessions. The latest close on file is 55.07. XLV traded between 166.19 and 168.74 across 2 sessions. The latest close on file is 167.68.
What the saved facts support for Select Sector Spdr Tr (XLV)
46 out of 100
“India slashes cost of cancer drugs after court rules mark-ups are ‘extortion’” scores 46 out of 100. The score uses 1 sources, and 8 linked companies.